Idogen AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, revenue was SEK 0.159 million compared to SEK 10.58 million a year ago. Net loss was SEK 36.29 million compared to SEK 25.33 million a year ago. Basic loss per share from continuing operations was SEK 0.58 compared to SEK 1.39 a year ago. Diluted loss per share from continuing operations was SEK 0.58 compared to SEK 1.39 a year ago.